Drug Approval

"Drug Approval" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Process that is gone through in order for a drug to receive approval by a government regulatory agency. This includes any required pre-clinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance of the drug.

Descriptor ID	D017277
MeSH Number(s)	E05.337.300 I01.880.604.605.250.250
Concept/Terms	Drug Approval Drug Approval Approval, Drug Approvals, Drug Drug Approvals Food and Drug Administration Drug Approval Drug Approval Process Drug Approval Process Approval Process, Drug Approval Processes, Drug Drug Approval Processes Process, Drug Approval Processes, Drug Approval New Drug Approval Process New Drug Approval Process New Drug Approval New Drug Approval Approval, New Drug Approvals, New Drug Drug Approval, New Drug Approvals, New New Drug Approvals Food and Drug Administration Drug Approval Process Food and Drug Administration Drug Approval Process

Below are MeSH descriptors whose meaning is more general than "Drug Approval".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Evaluation Studies as Topic [E05.337]
Drug Approval [E05.337.300]
Anthropology, Education, Sociology and Social Phenomena [I]
Social Sciences [I01]
Sociology [I01.880]
Social Control, Formal [I01.880.604]
Legislation, Drug [I01.880.604.605]
Drug and Narcotic Control [I01.880.604.605.250]
Drug Approval [I01.880.604.605.250.250]

Below are MeSH descriptors whose meaning is related to "Drug Approval".

Below are MeSH descriptors whose meaning is more specific than "Drug Approval".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Approval" by people in this website by year, and whether "Drug Approval" was a major or minor topic of these publications.

Bar chart showing 39 publications over 17 distinct years, with a maximum of 4 publications in 2013 and 2016 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2003	0	3	3
2004	0	1	1
2005	1	0	1
2007	1	0	1
2008	2	0	2
2009	0	2	2
2010	0	2	2
2011	2	1	3
2012	1	1	2
2013	1	3	4
2014	0	2	2
2015	1	2	3
2016	3	1	4
2017	1	1	2
2019	0	2	2
2020	3	1	4

Below are the most recent publications written about "Drug Approval" by people in Profiles.

Goudra B, Singh PM, Lichtenstein GR. Medical, Political, and Economic Considerations for the Use of MAC for Endoscopic Sedation: Big Price, Little Justification? Dig Dis Sci. 2020 09; 65(9):2466-2472.

View in: PubMed
Gopal AD, Wallach JD, Shah SA, Regillo C, Ross JS. On-Label and Off-Label Clinical Studies of FDA-Approved Ophthalmic Therapeutics. Ophthalmology. 2021 02; 128(2):332-334.

View in: PubMed
Parish LC, Lambert WC. COVID-19, Serendipity, and Strange Interlude: Gloria in Absurdicum with an Apology to Ovid. Skinmed. 2020; 18(3):143-144.

View in: PubMed
Khin NA, Francis G, Mulinde J, Grandinetti C, Skeete R, Yu B, Ayalew K, Cho SJ, Fisher A, Kleppinger C, Ayala R, Bonapace C, Dasgupta A, Kronstein PD, Vinter S. Data Integrity in Global Clinical Trials: Discussions From Joint US Food and Drug Administration and UK Medicines and Healthcare Products Regulatory Agency Good Clinical Practice Workshop. Clin Pharmacol Ther. 2020 11; 108(5):949-963.

View in: PubMed
Baker-Smith CM, de Ferranti SD, Cochran WJ. The Use of Nonnutritive Sweeteners in Children. Pediatrics. 2019 11; 144(5).

View in: PubMed
Wanderman N, Alvi M, Yolcu Y, Carlson B, Sebastian A, Bydon M, Freedman B. Is Teriparatide Beneficial to Spinal Fusion Surgery in the Older Patient?: A Narrative Review. Clin Spine Surg. 2019 06; 32(5):182-190.

View in: PubMed
Penazzato M, Gnanashanmugam D, Rojo P, Lallemant M, Lewis LL, Rocchi F, Saint Raymond A, Ford N, Hazra R, Giaquinto C, Belew Y, Gibb DM, Abrams EJ. Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations. Clin Infect Dis. 2017 Jun 01; 64(11):1597-1603.

View in: PubMed
Kuriyan AE, Albini TA, Flynn HW. The Growing "Stem Cell Clinic" Problem. Am J Ophthalmol. 2017 05; 177:xix-xx.

View in: PubMed
Butler J, Hamo CE, Udelson JE, Pitt B, Yancy C, Shah SJ, Desvigne-Nickens P, Bernstein HS, Clark RL, Depre C, Dinh W, Hamer A, Kay-Mugford P, Kramer F, Lefkowitz M, Lewis K, Maya J, Maybaum S, Patel MJ, Pollack PS, Roessig L, Rotman S, Salsali A, Sims JJ, Senni M, Rosano G, Dunnmon P, Stockbridge N, Anker SD, Zile MR, Gheorghiade M. Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction. Circ Heart Fail. 2016 Nov; 9(11).

View in: PubMed
Pirlamarla P, Bond RM. FDA labeling of NSAIDs: Review of nonsteroidal anti-inflammatory drugs in cardiovascular disease. Trends Cardiovasc Med. 2016 11; 26(8):675-680.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement